Nucleic Acids Research, 2000, Vol. 28, No. 21 4350-4355
© 2000 Oxford University Press
The age-related accumulation of a mitochondrial DNA control region mutation in muscle, but not brain, detected by a sensitive PNA-directed PCR clamping based method
Center for Molecular Medicine, Emory University School of Medicine, 1462 Clifton Road, Atlanta, GA 30322, USA
The peptide nucleic acid (PNA)-directed PCR clamping technique was modified and applied to the detection of mitochondrial DNA mutations with low heteroplasmy. This method is extremely specific, eliminating false positives in the absence of mutant molecules, and highly sensitive, being capable of detecting mutations at the level of 0.1% of total molecules. Moreover, the reaction can be multiplexed to identify more than one mutation per reaction. Using this technique, the levels of three point mutations, the tRNALeu(UUA) 3243 mutation causing mitochondrial encephalopathy, lactic acidosis and stroke-like episodes (MELAS); the tRNALys 8344 mutation causing myoclonic epilepsy and ragged red fibers (MERRF); and the nucleotide position 414 mutation adjacent to the control region promoters, were evaluated in human brain and muscle from individuals of various ages. While none of the mutations were detected in brain samples from individuals ranging in age from 23 to 93, the 414 mutation could be detected in muscle from individuals 30 years and older. These data demonstrate that the 3243 and 8344 mutations do not accumulate with age to levels greater than 0.1% in brain and muscle. By contrast, the 414 mutation accumulates with age in normal human muscle, though not in brain. The reason for the striking absence of the 414 mutation in aging brain is unknown.
* To whom correspondence should be addressed. Tel: +1 404 727 8368; Fax: +1 404 727 8367; Email: dwallace@gen.emory.edu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. C. Wallace and W. Fan The pathophysiology of mitochondrial disease as modeled in the mouse Genes & Dev., August 1, 2009; 23(15): 1714 - 1736. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Aschrafi, A. D. Schwechter, M. G. Mameza, O. Natera-Naranjo, A. E. Gioio, and B. B. Kaplan MicroRNA-338 Regulates Local Cytochrome c Oxidase IV mRNA Levels and Oxidative Phosphorylation in the Axons of Sympathetic Neurons J. Neurosci., November 19, 2008; 28(47): 12581 - 12590. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Krishnan, L. C. Greaves, A. K. Reeve, and D. Turnbull The ageing mitochondrial genome Nucleic Acids Res., December 3, 2007; 35(22): 7399 - 7405. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Jakupciak, W. Wang, M. E. Markowitz, D. Ally, M. Coble, S. Srivastava, A. Maitra, P. E. Barker, D. Sidransky, and C. D. O'Connell Mitochondrial DNA as a Cancer Biomarker J. Mol. Diagn., May 1, 2005; 7(2): 258 - 267. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Atilano, P. Coskun, M. Chwa, N. Jordan, V. Reddy, K. Le, D. C. Wallace, and M. C. Kenney Accumulation of Mitochondrial DNA Damage in Keratoconus Corneas Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1256 - 1263. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Urata, Y. Wada, S. H. Kim, W. Chumpia, Y. Kayamori, N. Hamasaki, and D. Kang High-Sensitivity Detection of the A3243G Mutation of Mitochondrial DNA by a Combination of Allele-Specific PCR and Peptide Nucleic Acid-Directed PCR Clamping Clin. Chem., November 1, 2004; 50(11): 2045 - 2051. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. E. Coskun, M. F. Beal, and D. C. Wallace Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication PNAS, July 20, 2004; 101(29): 10726 - 10731. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Coskun, E. Ruiz-Pesini, and D. C. Wallace Control region mtDNA variants: Longevity, climatic adaptation, and a forensic conundrum PNAS, March 4, 2003; 100(5): 2174 - 2176. [Full Text] [PDF]
|
|
|
|
|
|
D. K. Hancock, F. P. Schwarz, F. Song, L.-J. C. Wong, and B. C. Levin Design and Use of a Peptide Nucleic Acid for Detection of the Heteroplasmic Low-Frequency Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes (MELAS) Mutation in Human Mitochondrial DNA Clin. Chem., December 1, 2002; 48(12): 2155 - 2163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. W. Taylor, G. A. Taylor, S. E. Durham, and D. M. Turnbull The determination of complete human mitochondrial DNA sequences in single cells: implications for the study of somatic mitochondrial DNA point mutations Nucleic Acids Res., August 1, 2001; 29(15): e74 - e74. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wang, Y. Michikawa, C. Mallidis, Y. Bai, L. Woodhouse, K. E. Yarasheski, C. A. Miller, V. Askanas, W. K. Engel, S. Bhasin, et al. Muscle-specific mutations accumulate with aging in critical human mtDNA control sites for replication PNAS, March 7, 2001; (2001) 61013598. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Wang, Y. Michikawa, C. Mallidis, Y. Bai, L. Woodhouse, K. E. Yarasheski, C. A. Miller, V. Askanas, W. K. Engel, S. Bhasin, et al. Muscle-specific mutations accumulate with aging in critical human mtDNA control sites for replication PNAS, March 27, 2001; 98(7): 4022 - 4027. [Abstract] [Full Text] [PDF]
|
|